Benjamin L. Maughan - Concepedia

Author

Benjamin L. Maughan

Also Known As

B. Maughan, B.L. Maughan, Benjamin L Maughan, Benjamin L. Maughan, Benjamin Louis Maughan, Benjamin Maughan, Heng, Daniel Y. C.

386

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Utah Huntsman Cancer Institute Sidney Kimmel Comprehensive Cancer Center Dana-Farber Cancer Institute Harvard University

About

Benjamin L. Maughan is an author at University of Utah specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	23	741
2	Pharmacology	11	12	386
3	Pathology	9	9	348
4	Health Sciences	6	6	102
5	Immunology	3	3	57

Benjamin L. Maughan

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, Journal of Clinical Oncology	2017	468
<i>CDK12</i>-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors Emmanuel S. Antonarakis, Pedro Isaacsson Velho, Wei Fu, JCO Precision Oncology	2020	205
Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy. Shilpa Gupta, Guru Sonpavde, Christopher Weight, Journal of Clinical Oncology Radical CystectomySurgical OncologyUrologyPd-l1 ExpressionGenitourinary Cancer	2020	134
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum Lucia Nappi, Marisa Thi, Amy Lum, Journal of Clinical Oncology	2019	120
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE) Rana R. McKay, Bradley A. McGregor, Wanling Xie, Journal of Clinical Oncology	2020	103
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer Sophie J. Cowman, Daniel G. Fuja, Xian-De Liu, Clinical Cancer Research	2020	81
Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0 Georges Gebrael, Kamal Kant Sahu, Beverly Chigarira, Cancers	2023	76
Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, European Urology UrologySomatic VariantGenitourinary CancerMedicinePathology	2020	74
PD-1 checkpoint inhibition: Toxicities and management Andrew W. Hahn, David Gill, Neeraj Agarwal, Urologic Oncology Seminars and Original Investigations PharmacologyPd-1 Checkpoint InhibitionCancer TreatmentImmune Checkpoint Inhibitor	2017	68
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration‐Resistant Prostate Cancer: A Retrospective Study Benjamin L. Maughan, Brandon Luber, Rosa Nadal, The Prostate	2016	65

Page 1